Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings

Reuters
Jan 10
Stonegate Capital Partners Initiates Coverage on <a href="https://laohu8.com/S/NTHI">NeOnc Technologies Holdings</a>

Stonegate Capital Partners has initiated coverage on NeOnc Technologies Holdings Inc. (NASDAQ: NTHI), a clinical-stage life sciences company focused on central nervous system therapeutics. The company recently announced positive Phase 1/2a results for its lead asset, NEO100, with top-line Phase 2a data expected in mid-2026. The closing and funding of the Quazar Investment is also anticipated in the near term. For more details, visit https://www.newsfilecorp.com/release/193551

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neonc Technologies Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 279982) on January 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10